<DOC>
	<DOC>NCT01046357</DOC>
	<brief_summary>This is a Phase I, first time in human, randomised, blinded, placebo-controlled, single ascending dose study in healthy male volunteers conducted at a single centre. The effect of food on the pharmacokinetics of AZD7687 will also be studied. The study will consist of two parts, a dose escalation part and a food interaction part. The two parts will be run in parallel. In total, 64 healthy volunteers divided in 8 different panels (8 volunteers per cohort) will be exposed to single doses during the dose escalation. Each subject will receive dose only once, except for the volunteers included in the dose steps repeated for food interaction.</brief_summary>
	<brief_title>A Study in Healthy Volunteers to Assess the Tolerability and Blood Levels of a Single Dose of AZD7687</brief_title>
	<detailed_description />
	<criteria>Healthy BMI between 1930 No blood donation prior 30 days No other clinical study prior 3 months</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>First in human</keyword>
	<keyword>Safety</keyword>
</DOC>